.Atea Pharmaceuticals' antiviral has actually stopped working an additional COVID-19 test, yet the b...
.Neurocrine Biosciences' mental illness program pivot has fallen short. The biotech was not able to ...
.Sanofi has created a late access to the radioligand party, paying 100 thousand europeans ($ 110 tho...
.After F2G's very first try to acquire a new lesson of antifungal to market was actually thwarted by...
.Moderna has actually promised to reduce R&D investing through $1.1 billion by 2027. The choice t...
.Just 4 months after Sanofi bet $80 thousand in upfront cash money on Fulcrum Therapies' losmapimod,...
.Cancer company Oncternal Therapies is actually folding all its professional tests and laying off st...
.Roche is actually storing out chances that its own injectable obesity prospect could at some point ...
.Novo Nordisk has elevated the cover on a phase 1 test of its own dental amylin and GLP-1 receptor c...
.Only a couple of short weeks after succeeding an FDA Fast Track tag for its own investigational BTK...